Beijing Leadman Biochemistry Co.,Ltd. (SHE:300289)

China flag China · Delayed Price · Currency is CNY
6.81
+0.09 (1.34%)
Apr 1, 2026, 3:04 PM CST
Market Cap3.70B +37.3%
Revenue (ttm)326.31M -11.9%
Net Income-22.98M
EPS-0.04
Shares Out544.01M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume7,885,300
Average Volume6,065,054
Open6.35
Previous Close6.72
Day's Range6.35 - 6.83
52-Week Range3.85 - 11.67
Beta0.11
RSI51.15
Earnings DateMar 31, 2026

About SHE:300289

Beijing Leadman Biochemistry Co.,Ltd. researches and develops, manufactures, and sells vitro diagnostic reagents and instruments, and biochemical raw materials in the People’s Republic of China. The company offers biochemical raw materials, including enzymes, antigens, coenzymes, antibodies, buffers, enzyme substrates, culture mediums, stain agents, amino acids, and other products for biotechnology, clinical diagnosis, drug development, chemical production, and other related applications. It also provides biochemical reagents for liver and kidn... [Read more]

Sector Healthcare
Founded 1997
Employees 427
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 300289
Full Company Profile

Financial Performance

In 2025, SHE:300289's revenue was 326.31 million, a decrease of -11.86% compared to the previous year's 370.23 million. Losses were -22.98 million, -69.40% less than in 2024.

Financial Statements